Seeking Alpha

JoeNatural

View as an RSS Feed
View JoeNatural's Comments BY TICKER:
Latest  |  Highest rated
  • Can A New CEO Lead These Turnaround Stocks Higher? [View article]
    And the potentially most exciting of them all ..... UNXL .... not mentioned in this article.
    Apr 19 06:06 PM | Likes Like |Link to Comment
  • J.C. Penney: Sometimes The Market Gives You A Gift To Buy [View article]
    I guess everyone missed Mary Epner's assessment of JCP last Thursday ....

    http://cnb.cx/1euIgY8

    When asked what retailers would benefit the most this Spring. She immediately says, "JCP." Funny at that moment during the trading day when the stock was at $8.72, short-sellers immediately made sure the stock didn't trade up and then attacked hard right out of the gate the next morning in typical bear-raid fashion. The Gap report didn't help, but people don't realize that JCP probably took some business away from The Gap.

    The JCP I visited on Saturday looked great and the comeback is for real.
    Apr 16 01:01 AM | 2 Likes Like |Link to Comment
  • NQ: You Can't Fool All Of The People All Of The Time [View article]
    It's obvious that institutions are fleeing in droves and with the massive and repetitive dilution, there's no chance on earth that retailers can sustain any sort of move upwards whatsoever.
    Apr 15 08:32 AM | Likes Like |Link to Comment
  • J.C. Penney: What To Do After Yesterday's Plunge [View article]
    I figured that short-sellers became very nervous Thursday after what Mary Epner had to say on CNBC about JCP .... http://cnb.cx/1euIgY8

    Sure looked like JCP was attacked right out of the gate yesterday after Epner's very positive comments on JCP and let's not forget that retailers got whacked yesterday after the report by The Gap (GPS).

    This is one stock (JCP) I'm hanging on to for several years, as I believe the turnaround not only takes them back to where they once were, but to even greater heights. The stores look awesome and the prices are soooooo affordable.
    Apr 12 10:15 AM | 3 Likes Like |Link to Comment
  • Rubicon Project's Latest IPO [View article]
    ADTM is the stock to watch in this sector. It trades on the OTC and saw 1,400% sequential revenue growth last quarter and Q4 numbers should be out any day and most likely we'll see big sequential growth yet again. Wayyyy under the radar, but some noteable players involved.
    Apr 11 10:51 AM | Likes Like |Link to Comment
  • Adamis Pharmaceuticals: Still No Love After Uplisting To Nasdaq [View article]
    Looks like someone else is interested .......

    http://bit.ly/YqXG13
    Apr 9 03:53 PM | Likes Like |Link to Comment
  • GeoInvesting Publishes Evidence On L&L Energy: Canaries In LuoZhou And LaShu Coalmines [View article]
    Nice work Geo !!
    Apr 8 07:24 PM | 2 Likes Like |Link to Comment
  • Adamis Pharmaceuticals: Still No Love After Uplisting To Nasdaq [View article]
    He knows the big picture, but apparently short the stock, just as he shorts anything and everything. LOL. Fine with me, as much bigger money and stronger hands are coming into the stock and I'll gladly accept additional fuel for the upside.
    Apr 8 02:36 PM | 5 Likes Like |Link to Comment
  • Adamis Pharmaceuticals: Still No Love After Uplisting To Nasdaq [View article]
    The NDA is expected to be filed later this month.
    Apr 8 01:51 PM | 4 Likes Like |Link to Comment
  • Adamis Pharmaceuticals: Still No Love After Uplisting To Nasdaq [View article]
    Robert, let's see what the stock does when Adamis proves they can deliver 25% less drug with the same efficacy as Advair. That day is coming IMO and pretty fast. When it does, you can throw out the "double or triple" I stated in the first paragraph of the article, as then we'll be discussing multi-bags.
    Apr 8 01:43 PM | 3 Likes Like |Link to Comment
  • Adamis Pharmaceuticals: Still No Love After Uplisting To Nasdaq [View article]
    Robert, obviously you didn't hit any of the above links within the article that clearly point to 3M's research that indicate superiority in head to head testing against Glaxo's Advair. I didn't insert those links just for fun, but for people to evaluate the evidence.

    And many offerings ? LOL. They'll have big pharma beating their door down after the conclusion of this summer's trials. If there by chance happens to be another offering early next year, it will be at much much higher prices IMO. I'll be stunned if they don't have a partner by then to foot any and all expenses going forward.
    Apr 8 01:07 PM | 6 Likes Like |Link to Comment
  • Adamis Pharmaceuticals: Still No Love After Uplisting To Nasdaq [View article]
    People don't realize that if ADMP gets just a 10% share of the generic Advair market (I think that's low) with the very best product made, that's $800 million in revenues. Never mind the other 7 drug candidates in ADMP's pipeline.

    QCOR bought Acthar for $100K and sold it yesterday for $5.6 billion. APC-5000 is the next Acthar IMO. Absolutely no one has caught on to this story yet. They will.
    Apr 8 12:23 PM | 5 Likes Like |Link to Comment
  • Take Advantage Of Legislative Grandstanding By Buying Gilead At A Discount [View article]
    The quicker this country wakes up and stops electing Democrats that are focused on destroying wealth, the quicker we flourish together as a nation.
    Mar 29 10:04 AM | Likes Like |Link to Comment
  • Prepare For Blastoff: New Research On NQ Mobile [View article]
    Definitely the longest SA article ever written. Bottom line here is that NQ loves to sell stock and IMO is a ChiScam. No time to write anything further at the moment.
    Mar 27 06:37 PM | 1 Like Like |Link to Comment
  • WidePoint - An Attractive Acquisition Target Within The Cloud Which Is Due To Triple; $6.50 Price Target [View article]
    I'm not sure how one can claim the stock to be undervalued after the stock just doubled and management has since heavily diluted shareholders. Meanwhile, Q4 EPS will be lucky to show breakeven and my phone conversation with the CFO leads me to believe that full year 2014 EPS might come in somewhere between 0.00 and .07 ..... if anything, one can certainly make the claim that the stock's wayyyyy overvalued. 2015 may offer a true turnaround scenario, but you can stick a fork in 2014 as far as earnings is concerned.
    Mar 20 09:16 AM | Likes Like |Link to Comment
COMMENTS STATS
731 Comments
1,270 Likes